Skip to main content
. 2016 Aug 29;9:199–205. doi: 10.1016/j.dib.2016.08.039

Table 5.

Statistical analysis of salbutamol/albuterol usage in the PD analysis set.

Day QAW039 Placebo Treatment difference QAW039-placebo
1–7 2.056 (1.731, 2.441) 1.917 (1.621, 2.266) 1.072 (0.844, 1.363)NS
7–14 2.111 (1.795, 2.483) 2.047 (1.754, 2.390) 1.031 (0.824, 1.290)NS
14–21 1.929 (1.625, 2.291) 2.018 (1.725, 2.363) 0.956 (0.757, 1.207)NS
21–28 1.748 (1.468, 2.080) 1.903 (1.628, 2.224) 0.919 (0.727, 1.160)NS

Data are least squares mean, 90% CI.

NS, not significant.